A newly-designed material, which mimics the wing structure of owls, could help make wind turbines, computer fans and even planes much quieter. Early wind tunnel tests of the coating have shown a substantial reduction in noise without any noticeable effect on aerodynamics.
Innovation is about the application of new ideas, discoveries and inventions. The innovative and entrepreneurial spirit of the members of the University of Cambridge is enshrined in the University’s mission statement to contribute to society through the pursuit of education, learning and research at the highest international levels of excellence. The foundation for innovation is the steady supply of excellent ideas, of which there is an abundance at Cambridge. Ingenuity and creativity, alongside the fundamental research which underpins these ideas and combined with the constant exchange of ideas between academics and companies, governments and NGOs has been the recipe for this success.
Various mechanisms are in place to help our academics nurture future innovation. As well as dedicated departmental support structures, Cambridge Enterprise provides technology transfer, consultancy services and seed fund opportunities, and the Centre for Entrepreneurial Learning (CfEL) within the Judge Business School provides networking opportunities with peers. In addition, Cambridge-based initiatives physically embedded within the University such as ideaSpace provide hubs for entrepreneurs to develop ideas.
New funding will support fundamental research into the molecular processes underlying human disorders such as Alzheimer’s and Parkinson’s diseases, and enable new ways to combat them.
Europe's Graphene Flagship lays out a science and technology roadmap, targeting research areas designed to take graphene and related two-dimensional materials from academic laboratories into society.
The European alternative finance market - which includes crowdfunding, peer-to-peer lending and invoice trading - reached €3 billion last year and could top €7 billion in 2015, as businesses increasingly seek more efficient ways to raise funding.
Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30 million Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and UCL (University College London). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer’s disease and other dementias.